National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings
Federal Register, Volume 82 Issue 3 (Thursday, January 5, 2017)
Federal Register Volume 82, Number 3 (Thursday, January 5, 2017)
Notices
Page 1359
From the Federal Register Online via the Government Publishing Office www.gpo.gov
FR Doc No: 2016-31983
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the National Diabetes and Digestive and Kidney DiseasesAdvisory Council.
The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign languageinterpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and thediscussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council.
Date: February 1, 2017.
Open: 8:30 a.m. to 12:00 p.m.
Agenda: To present the Director's Report and other scientific presentations.
Place: National Institutes of Health, Building 31, C Wing 6th Floor, Conference Center, Room 10, 31 Center Drive, Bethesda, MD 20892.
Closed: 3:45 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, C Wing 6th Floor, Conference Center, Room 10, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, Ph.D., Director, Division of Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd. Room 7323, MSC 5452, Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council; Kidney, Urologic and Hematologic Diseases Subcommittee.
Date: February 1, 2017.
Open: 1:00 p.m. to 3:00 p.m.
Agenda: To review the Division's scientific and planning activities.
Place: National Institutes of Health, Building 31, C Wing 6th Floor, Conference Center, Room 7, 31 Center Drive, Bethesda, MD 20892.
Closed: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, C Wing 6th Floor, Conference Center, Room 7, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, Ph.D., Director, Division of Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd. Room 7323, MSC 5452, Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council; Digestive Diseases and Nutrition Subcommittee.
Date: February 1, 2017.
Open: 1:00 p.m. to 2:30 p.m.
Agenda: To review the Division's scientific and planning activities.
Place: National Institutes of Health, Building 31, C Wing 6th Floor, Conference Center, Room 6, 31 Center Drive, Bethesda, MD 20892.
Open: 2:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, C Wing 6th Floor, Conference Center, Room 6, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, Ph.D., Director, Division of Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd. Room 7323, MSC 5452, Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council; Diabetes, Endocrinology and Metabolic Diseases Subcommittee.
Date: February 1, 2017.
Open: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building, 31, C Wing 6th floor, Conference Center, Room 10, 31 Center Drive, Bethesda, MD 20892.
Open: 2:00 p.m. to 4:00 p.m.
Agenda: To review the Division's scientific and planning activities.
Place: National Institutes of Health, Building, 31, C Wing 6th floor, Conference Center, Room 10, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, Ph.D., Director, Division of Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd. Room 7323, MSC 5452, Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.
Information is also available on the Institute's/Center's home page: www.niddk.nih.gov/fund/divisions/DEA/Council/coundesc.htm., where an agenda and any additional information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)
Dated: December 29, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 2016-31983 Filed 1-4-17; 8:45 am
BILLING CODE 4140-01-P
